InnovAge Appoints Dr. Paul Taheri as Chief Medical Officer
Rhea-AI Summary
InnovAge (Nasdaq: INNV) appointed Paul Taheri, MD, MBA as Chief Medical Officer, effective November 3, 2025. Dr. Taheri is a board-certified trauma surgeon with more than 30 years of healthcare leadership, including roles as CEO and Deputy Dean for Clinical Affairs at Yale School of Medicine and CEO of the University of Vermont Medical Group. He has served as a Clinical Quality Advisor since 2019 and holds an MBA from the University of Michigan.
InnovAge serves approximately 7,740 participants across 20 centers in six states as of June 30, 2025; the appointment is framed as strengthening clinical leadership for the company’s PACE model.
Positive
- Appointment effective November 3, 2025
- 30+ years of clinical and executive healthcare experience
- InnovAge served ~7,740 participants as of June 30, 2025
Negative
- None.
News Market Reaction 5 Alerts
On the day this news was published, INNV gained 5.57%, reflecting a notable positive market reaction. Argus tracked a peak move of +4.8% during that session. Argus tracked a trough of -6.4% from its starting point during tracking. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $35M to the company's valuation, bringing the market cap to $669M at that time. Trading volume was above average at 1.9x the daily average, suggesting increased trading activity.
Data tracked by StockTitan Argus on the day of publication.
DENVER, Nov. 03, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Paul Taheri, MD, MBA as its Chief Medical Officer, effective November 3, 2025.
Dr. Paul Taheri, a board-certified trauma surgeon, brings more than 30 years of healthcare leadership to InnovAge. He has served as a Clinical Quality Advisor to Welsh, Carson, Anderson & Stowe, a role he has held since 2019. Dr. Taheri previously served as CEO and Deputy Dean for Clinical Affairs at the Yale School of Medicine. His earlier leadership roles include President and CEO of the University of Vermont Medical Group, Senior Associate Dean for Clinical Affairs, and professor of surgery. He also held key positions at the University of Michigan in Ann Arbor, where he earned his MBA from the Ross School of Business. Dr. Taheri received his medical degree from New York University and completed his surgical residency at Tulane University.
“Paul brings a rare combination of clinical excellence, operational discipline, and strategic leadership to InnovAge,” said Patrick Blair, CEO. “With more than 3 decades of healthcare experience and his knowledge as a provider, we welcome him to InnovAge and are excited about the experience and stead leadership we expect him to bring to our clinical teams and the participants we serve every day.”
About InnovAge
InnovAge is a market leader in managing the care of high-cost, dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). With a mission of enabling older adults to age independently in their own homes for as long as safely possible, InnovAge’s patient-centered care model is designed to improve the quality of care its participants receive while reducing over-utilization of high-cost care settings. InnovAge believes its PACE healthcare model is one in which all constituencies — participants, their families, providers, and government payors — “win.” As of June 30, 2025, InnovAge served approximately 7,740 participants across 20 centers in six states. https://www.innovage.com/.
Investor Contact:
Ryan Kubota
RKubota@InnovAge.com
Media Contact:
Lara Hazenfield
Lhazenfied@InnovAge.com
This press release was published by a CLEAR® Verified individual.
FAQ
Who is InnovAge’s new Chief Medical Officer and when did the appointment take effect for INNV?
What clinical and leadership experience does InnovAge CMO Paul Taheri have?
How many participants does InnovAge (INNV) serve and in how many centers as of mid-2025?
What education does InnovAge’s new CMO hold and where did he earn his MBA?
What role did Paul Taheri hold with Welsh, Carson, Anderson & Stowe before joining InnovAge?
What does the CMO appointment mean for InnovAge’s PACE model and participants (INNV)?
